Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study

INTRODUCTION: For people with type 2 diabetes mellitus (T2DM) who require an antidiabetic drug as an add-on to metformin, there is controversy about whether newer drug classes such as dipeptidyl peptidase-4 inhibitors (DPP4i) or sodium-glucose co-transporter-2 inhibitors (SGLT2i) reduce the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidulka, Patrick, O’Neill, Stephen, Basu, Anirban, Wilkinson, Samantha, Silverwood, Richard J, Charlton, Paul, Briggs, Andrew, Adler, Amanda I, Khunti, Kamlesh, Tomlinson, Laurie A, Smeeth, Liam, Douglas, Ian J, Grieve, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477338/
https://www.ncbi.nlm.nih.gov/pubmed/34580091
http://dx.doi.org/10.1136/bmjopen-2020-046912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477338/
https://www.ncbi.nlm.nih.gov/pubmed/34580091
http://dx.doi.org/10.1136/bmjopen-2020-046912

Ejemplares similares